Table 1.
Enzyme | Associated cognitive disease | OMIM # | Mutation type | References |
---|---|---|---|---|
KMT2A | Wiedemann–Steiner syndrome | 605130 | Predicted LOF | [12, 97–99] |
KMT2B | Dystonia 28 | 617284 | Predicted LOF | [13, 100] |
KMT2C | Kleefstra syndrome 2 | 617768 | Predicted LOF | [14, 98, 101–103] |
KMT2D | Kabuki syndrome 1 | 147920 | Predicted LOF | [15, 104] |
KMT2E | ASD | n/a | Predicted LOF | [16] |
KMT2F | Schizophrenia | n/a | Predicted LOF | [19, 105] |
KDM1A | CPRF | 616728 | Unknown | [17, 106] |
KDM5A | ID | n/a | Predicted LOF | [107] |
KDM5B | ASD, ID | n/a | Unknown | [97, 102, 103, 108] |
KDM5C | Claes–Jensen syndrome, ASD | 300534 | Predicted LOF | [18, 109] |
Associated disease(s) are listed in the second column. Online Mendelian Inheritance in Man (OMIM) # reported for each disease in the third column. Mutation type, if predicted or unknown, reported in the fourth column (LOF loss of function). References contributing significantly to an understanding of disease etiology or clinical manifestations are listed in the fifth column